Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery
Background To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye...
Saved in:
| Published in | BMC ophthalmology Vol. 23; no. 1; pp. 167 - 10 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
20.04.2023
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2415 1471-2415 |
| DOI | 10.1186/s12886-023-02857-w |
Cover
| Abstract | Background
To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries.
Methods
In this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery.
Results
Tear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (
P
≤ 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD.
Conclusion
VIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes.
Trial registration
The trial registration number: 2021JS22. Date of registration: 10 May 2021. |
|---|---|
| AbstractList | Background To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries. Methods In this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery. Results Tear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (P [less than or equai to] 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD. Conclusion VIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes. Trial registration The trial registration number: 2021JS22. Date of registration: 10 May 2021. Keywords: Dry eye, FS-LASIK, LASEK, Vasoactive intestinal peptide, Corneal ablation depth To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries. In this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery. Tear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (P [less than or equai to] 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD. VIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes. Background To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries. Methods In this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery. Results Tear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery ( P ≤ 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD. Conclusion VIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes. Trial registration The trial registration number: 2021JS22. Date of registration: 10 May 2021. Abstract Background To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries. Methods In this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery. Results Tear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (P ≤ 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD. Conclusion VIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes. Trial registration The trial registration number: 2021JS22. Date of registration: 10 May 2021. BackgroundTo explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries.MethodsIn this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery.ResultsTear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (P ≤ 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD.ConclusionVIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes.Trial registrationThe trial registration number: 2021JS22. Date of registration: 10 May 2021. To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries.BACKGROUNDTo explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries.In this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery.METHODSIn this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery.Tear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (P ≤ 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD.RESULTSTear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (P ≤ 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD.VIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes.CONCLUSIONVIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes.The trial registration number: 2021JS22. Date of registration: 10 May 2021.TRIAL REGISTRATIONThe trial registration number: 2021JS22. Date of registration: 10 May 2021. To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgeries and related factors, possible association between postoperative dry eye symptoms and VIP concentration in tears, and factors influencing dry eye symptoms after different periods post LASEK and FS-LASIK surgeries. In this prospective, non-randomized, longitudinal cohort study, 23 and 22 subjects were recruited and underwent LASEK and FS-LASIK, respectively. After conducting an intact ophthalmic examination and collecting relevant surgical data, all subjects were examined for VIP concentration in their tears using ELISAs, tear-film breakup time, ocular staining and ocular surface disease index questionnaire before surgery and 1 day, 1 week, and 1 month post-surgery. Tear VIP concentration increased significantly after both LASEK and FS-LASIK, with the highest concentration observed 1 week post-surgery (P ≤ 0.05). Tear VIP concentration correlated negatively with corneal ablation depth (AD). The extent of dry eyes was related to the operation method employed and postoperative recovery period. In FS-LASIK and LASEK subjects, dry eyes were mainly affected by the basic ocular surface status before surgery, and VIP concentration. Furthermore, in LASEK subjects, dry eyes were negatively correlated with AD. VIP was stimulated and mobilized as an emergency protection post-refractive surgery and a trauma model affected by AD. It can indirectly indicate the inevitable relationship between postoperative dry eye and nerve injury. Elevated post-surgery tear VIP relieves dry eye symptoms, showing its neuroimmune role in regulating adverse injury stimulation. The present study provides a solution to the pathogenesis of postoperative dry eyes. The trial registration number: 2021JS22. Date of registration: 10 May 2021. |
| ArticleNumber | 167 |
| Audience | Academic |
| Author | Zhang, Hong Wu, Qiong Kang, Yang Hu, Qi Li, Xue Guo, Zidan |
| Author_xml | – sequence: 1 givenname: Yang surname: Kang fullname: Kang, Yang organization: Eye Hospital, The First Affiliated Hospital of Harbin Medical University – sequence: 2 givenname: Qi surname: Hu fullname: Hu, Qi organization: Eye Hospital, The First Affiliated Hospital of Harbin Medical University – sequence: 3 givenname: Xue surname: Li fullname: Li, Xue organization: Eye Hospital, The First Affiliated Hospital of Harbin Medical University – sequence: 4 givenname: Zidan surname: Guo fullname: Guo, Zidan organization: Outpatient department of Harbin Medical University, Harbin Medical University – sequence: 5 givenname: Qiong surname: Wu fullname: Wu, Qiong organization: Eye Hospital, The First Affiliated Hospital of Harbin Medical University – sequence: 6 givenname: Hong surname: Zhang fullname: Zhang, Hong email: zhanghong@hrbmu.edu.cn organization: Eye Hospital, The First Affiliated Hospital of Harbin Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37081425$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kkuLFDEUhQsZcR76B1xIgRs3Nead1EqGwcfAgCC6chFuJzdt2upKm1T30P_e9HQ7DxEJeZB854SbnNPmaEwjNs1LSs4pNeptocwY1RHGazdSdzdPmhMqNO2YoPLowfq4OS1lQQgjgptnzTHXxFDB5Enz_UsasE2hnRByu4GSwE1xg20cJyxTHGFoV7iaoq_U2Pq8bXGLpYUwYW4HKHX8iRmmlDHkg7as8xzz9nnzNMBQ8MVhPmu-fXj_9fJTd_3549XlxXXnpOynrufUO6GURC2Ru4DIjPKMGuTSSwHgQ-BU6dnMIJ2RIB0TzGiukStBPeVnzdXe1ydY2FWOS8hbmyDa242U5xbyFN2ANhjTG6WBCaAiOIAedWA9Id5Ipx1Ur3d7r9V6tkTvcJwyDI9MH5-M8Yedp42lhFJFel4d3hwccvq1rm9ol7E4HAYYMa2LZYZIwrSQO_T1X-girXN98h1FpSKEKHVPzaFWEMeQ6sVuZ2ovtFCCc6FJpc7_QdXmcRldDU6Idf-R4NXDSu9K_JONCrA94HIqpX7vHUKJ3QXQ7gNoawDtbQDtTRXxvahUeKwpuC_pP6rfLeDdSw |
| Cites_doi | 10.1016/j.jtos.2018.09.005 10.1097/ICO.0000000000002152 10.1016/j.exer.2022.108973 10.1007/s00417-015-3120-1 10.1097/OPX.0000000000001063 10.1016/j.jtos.2020.07.002 10.1016/j.sjopt.2013.09.004 10.1097/ICO.0000000000002312 10.1177/1120672120980346 10.1016/j.nlm.2017.10.010 10.1167/iovs.12-11264 10.1097/PR9.0000000000000664 10.1038/nn.3144 10.1155/2018/4903831 10.1016/j.jcrs.2016.05.008 10.1016/j.jcrs.2015.06.037 10.1016/j.jcrs.2012.01.028 10.1016/j.ophtha.2014.11.006 10.1159/000486859 10.1155/2020/7296412 10.1001/archophthalmol.2011.200 10.1016/j.exer.2020.108428 10.1007/s00417-017-3825-4 10.2147/OPTH.S169091 10.1167/iovs.17-23538 10.1016/j.ajpath.2020.06.013 10.1016/j.jtos.2016.10.003 10.1167/iovs.18-26051 10.1038/ncomms12034 10.2147/OPTH.S195991 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12886-023-02857-w |
| DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2415 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_f889867a24a14fcaa9e7f2900d85c7ca PMC10116093 A746433470 37081425 10_1186_s12886_023_02857_w |
| Genre | Clinical Trial Journal Article |
| GeographicLocations | Fort Worth Texas United States--US Germany |
| GeographicLocations_xml | – name: Fort Worth Texas – name: United States--US – name: Germany |
| GrantInformation_xml | – fundername: the Research Innovation Fund of Harbin Medical University grantid: 2019B04 – fundername: the Natural Science Foundation of China grantid: 81970776 – fundername: the Natural Science Foundation of Heilongjiang Province, China grantid: 2020H039 – fundername: ; grantid: 2019B04 – fundername: ; grantid: 81970776 – fundername: ; grantid: 2020H039 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM PMFND 7TK 7XB 8FK AZQEC COVID DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c559t-931dc4665e75e3cfee286d218e35d54aadff3167bb8e1b0f5c2428737e3641d13 |
| IEDL.DBID | M48 |
| ISSN | 1471-2415 |
| IngestDate | Wed Aug 27 00:45:13 EDT 2025 Tue Sep 30 17:15:00 EDT 2025 Fri Sep 05 05:18:46 EDT 2025 Fri Jul 25 07:23:17 EDT 2025 Tue Jun 17 21:48:15 EDT 2025 Tue Jun 10 20:34:05 EDT 2025 Thu Jan 02 22:52:35 EST 2025 Wed Oct 01 03:12:47 EDT 2025 Sat Sep 06 07:22:24 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | LASEK Dry eye Corneal ablation depth Vasoactive intestinal peptide FS-LASIK |
| Language | English |
| License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c559t-931dc4665e75e3cfee286d218e35d54aadff3167bb8e1b0f5c2428737e3641d13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://doaj.org/article/f889867a24a14fcaa9e7f2900d85c7ca |
| PMID | 37081425 |
| PQID | 2815600066 |
| PQPubID | 44797 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f889867a24a14fcaa9e7f2900d85c7ca pubmedcentral_primary_oai_pubmedcentral_nih_gov_10116093 proquest_miscellaneous_2805027453 proquest_journals_2815600066 gale_infotracmisc_A746433470 gale_infotracacademiconefile_A746433470 pubmed_primary_37081425 crossref_primary_10_1186_s12886_023_02857_w springer_journals_10_1186_s12886_023_02857_w |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-04-20 |
| PublicationDateYYYYMMDD | 2023-04-20 |
| PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC ophthalmology |
| PublicationTitleAbbrev | BMC Ophthalmol |
| PublicationTitleAlternate | BMC Ophthalmol |
| PublicationYear | 2023 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | 2857_CR28 2857_CR29 2857_CR26 2857_CR27 2857_CR24 2857_CR25 2857_CR22 2857_CR20 2857_CR21 O Assaf Gershoni (2857_CR18) 2021; Nov31 RR Laura García-Posadas (2857_CR30) 2020; 190 A Yukio Ago (2857_CR23) 2017; Nov145 2857_CR9 2857_CR8 2857_CR7 2857_CR6 2857_CR1 2857_CR19 2857_CR17 2857_CR5 2857_CR15 2857_CR4 2857_CR16 2857_CR3 2857_CR13 2857_CR35 2857_CR2 2857_CR14 2857_CR11 2857_CR33 2857_CR12 2857_CR34 2857_CR31 2857_CR10 2857_CR32 |
| References_xml | – ident: 2857_CR5 doi: 10.1016/j.jtos.2018.09.005 – ident: 2857_CR6 doi: 10.1097/ICO.0000000000002152 – ident: 2857_CR7 doi: 10.1016/j.exer.2022.108973 – ident: 2857_CR33 doi: 10.1007/s00417-015-3120-1 – ident: 2857_CR21 doi: 10.1097/OPX.0000000000001063 – ident: 2857_CR29 doi: 10.1016/j.jtos.2020.07.002 – ident: 2857_CR15 doi: 10.1016/j.sjopt.2013.09.004 – ident: 2857_CR34 doi: 10.1097/ICO.0000000000002312 – ident: 2857_CR10 doi: 10.1007/s00417-015-3120-1 – ident: 2857_CR19 doi: 10.1177/1120672120980346 – ident: 2857_CR9 – volume: Nov145 start-page: 222 year: 2017 ident: 2857_CR23 publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2017.10.010 – ident: 2857_CR16 doi: 10.1167/iovs.12-11264 – ident: 2857_CR32 doi: 10.1097/PR9.0000000000000664 – ident: 2857_CR12 doi: 10.1038/nn.3144 – ident: 2857_CR35 doi: 10.1155/2018/4903831 – ident: 2857_CR20 doi: 10.1097/OPX.0000000000001063 – ident: 2857_CR31 doi: 10.1016/j.jcrs.2016.05.008 – ident: 2857_CR4 doi: 10.1016/j.jcrs.2015.06.037 – ident: 2857_CR22 doi: 10.1016/j.jcrs.2012.01.028 – ident: 2857_CR25 doi: 10.1016/j.ophtha.2014.11.006 – ident: 2857_CR27 doi: 10.1159/000486859 – ident: 2857_CR8 doi: 10.1155/2020/7296412 – ident: 2857_CR26 doi: 10.1001/archophthalmol.2011.200 – ident: 2857_CR14 doi: 10.1016/j.exer.2020.108428 – ident: 2857_CR17 doi: 10.1007/s00417-017-3825-4 – ident: 2857_CR3 doi: 10.2147/OPTH.S169091 – ident: 2857_CR1 doi: 10.1167/iovs.17-23538 – volume: 190 start-page: 2067 issue: 10 year: 2020 ident: 2857_CR30 publication-title: Am J Pathol Oct doi: 10.1016/j.ajpath.2020.06.013 – ident: 2857_CR28 – ident: 2857_CR13 doi: 10.1016/j.jtos.2016.10.003 – ident: 2857_CR11 doi: 10.1167/iovs.18-26051 – ident: 2857_CR24 doi: 10.1038/ncomms12034 – ident: 2857_CR2 doi: 10.2147/OPTH.S195991 – volume: Nov31 start-page: 2914 issue: 6 year: 2021 ident: 2857_CR18 publication-title: Eur J Ophthalmol doi: 10.1177/1120672120980346 |
| SSID | ssj0020438 |
| Score | 2.3004096 |
| Snippet | Background
To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and... To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and femtosecond... Background To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and... BackgroundTo explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis (LASEK) and... Abstract Background To explore the changes in vasoactive intestinal peptide (VIP) concentration in tears post laser-assisted sub-epithelial keratomileusis... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 167 |
| SubjectTerms | Ablation Analysis Cohort Studies Cornea Cornea - physiology Cornea - surgery Corneal ablation depth Dry eye Dry Eye Syndromes - etiology Exocrine glands Eye Eye diseases Eye surgery FS-LASIK Hospitals Humans Injuries Intestine Keratomileusis, Laser In Situ - adverse effects Keratomileusis, Laser In Situ - methods Laboratories Lacerations LASEK Lasers Lasers, Excimer - therapeutic use Longitudinal Studies Mediation Medicine Medicine & Public Health Myopia - surgery Neuropeptides Ocular Surface Diseases Ophthalmology Peptides Prospective Studies Software Surgery Tears Topography Vasoactive agents Vasoactive Intestinal Peptide Vasoactive intestinal peptides |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_Sg3gRv11tZQXBgy7dzccmOVaxFKEexELBQ8hLJijKbnn7aul_35ns7rNbES9e3mEzeSTzy3wxkwljrxrrPfjEK5m8qmTgqrI6hkpaH21tgoecPT_-1B6dyI-n6vTaU19UEza2Bx4Zt5-MsabVnkvfyBS8t6ATt3UdjQo6ZNcIzdgcTE2hFuW35isypt0fUAsbKralnCU1P7pYmKHcrf9PnXzNKN0smLyRNc3G6PAeuzt5keXBuPr77BZ0D9jt4ylP_pB9_dz_hLJPJVXrlr_80Pus10rqDoFCTZPPqJ4lIlVXxvVlCZcwlPnF8BIdavz9ATkDD2k9zR3GG9SP2Mnhhy_vj6rpGYUqYLiwqaxoYpBtq0ArECEBcNNGNO0gVFTS-5gS3YdfrQw0qzqpwCmOEhpEK5vYiMdsp-s7eMrKiBLMlfAhekANK1aC1whnEDZ5aLQo2JuZq-5s7JbhcpRhWjdi4BADlzFwFwV7R4zfUlKn6_wB8XcT_u5f-BfsNcHmSB4Rm-CnawW4YOps5Q60RKdLSF0XbHdBiXIUlsMz8G6S48FxaqaT_bKCvdwO00yqTeugPyeaWlFwr3D7T8Zzst2S0OhyoVosmFmcoMWelyPd92-5y3dDKbLa4p--nQ_b73X9nanP_gdTn7M7PAuLRC26y3Y263PYQ-drs3qR5ewK928swg priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Ni9QwNOgK4kX8trpKBcGDlm3z0aQnWcVlEdaDuDDgIWSSFxWlHaezLvvvfS9tZ-yKXnpoktLkfed9Mfa8apwDF3kho1OF9FwVjQ6-kI0LTWm8g-Q9P_lQH5_K9wu1GC_c-jGscuKJiVGHztMd-QGnsiZJQr5e_SyoaxR5V8cWGlfZtQpVFcJqvdgZXOTlmhJlTH3QIy82FHJLnksqgXQ-E0apZv_fnPkP0XQ5bPKS7zSJpKNb7OaoS-aHA_BvsyvQ3mHXT0Zv-V32-WP3A_Iu5hSzm_9yfecSd8upRgSSNi1eUVRLwFltHtYXOVxAn6e-4Tmq1fj8DskPD3E9ru2HPOp77PTo3ae3x8XYTKHwaDRsikZUwcu6VqAVCB8BuKkDCngQKijpXIiRsuKXSwPVsozKc7KmhAZRyypU4j7ba7sWHrI8IB1zJZwPDpDPiqXgJQLViyY6qLTI2MvpVO1qqJlhk61hajvAwCIMbIKBPc_YGzr47Uyqd51edOsvdiQfG41pTK0dl66S0TvXgI68KctglNfeZewFgc0SVSJsvBuTC_CHqb6VPdQSVS8hdZmx_dlMpCY_H54Ab0dq7u0O9zL2bDtMKylCrYXujOaUikx8hdt_MODJdktCo-KFzDFjZoZBsz3PR9pvX1Ot74ocZWWDH301Idvuv_59qI_-v43H7AZPZCCRS-6zvc36DJ6gcrVZPk0U9BtdkSOd priority: 102 providerName: ProQuest – databaseName: SpringerOpen Free (Free internet resource, activated by CARLI) dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NaxUxEA9aQbyI366tEkHwoIu7-dhNjvVhKUI9iIWCh5CXTFCU3fL21dL_vjPZfc9u1YOXd9hMHpv8MpMZZua3jL2qrffgkyhV8rpUQejStjGUyvpoKxM85Oz50afm8Fh9PNEnE00O9cJczd_Xpnk3oP00VCZL2UaiLTq_yW5pNLxUvrdoFtvgijJam6aYv86bXTyZn_9PK3zlGrpeInktT5qvn4N77O7kN_L9Eej77AZ0D9jtoykz_pB9_dz_BN4nTvW5_Jcfep8tGSc-CFRjmnxKFSwRpToeVxccLmDg-RvhHF1o_P0BOecOaTXNHcae6Ufs-ODDl8VhOX04oQwYIKxLK-sYVNNoaDXIkACEaSJe5iB11Mr7mBJ1wC-XBupllXQQFDnJFmSj6ljLx2yn6zt4ynhEnRVa-hA9oE2VSykqBDBImzzUrSzYm82uutORH8PluMI0bsTAIQYuY-DOC_aeNn4rSdzW-QFC7iZVcckYa5rWC-VrlYL3FtokbFVFo0MbfMFeE2yONBCxCX5qJMAXJi4rt98qdLOkaquC7c0kUXPCfHgDvJs0d3CC6HOyJ1awl9thmknVaB30ZyRTaQrnNS7_yXhOtkuSLTpZaAgLZmYnaLbm-Uj3_Vvm9a4pKVZZ_NO3m8P2-73-vanP_k98l90RWS0UWsg9trNencFzdKzWyxdZoy4B_ysdHQ priority: 102 providerName: Springer Nature |
| Title | Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery |
| URI | https://link.springer.com/article/10.1186/s12886-023-02857-w https://www.ncbi.nlm.nih.gov/pubmed/37081425 https://www.proquest.com/docview/2815600066 https://www.proquest.com/docview/2805027453 https://pubmed.ncbi.nlm.nih.gov/PMC10116093 https://doaj.org/article/f889867a24a14fcaa9e7f2900d85c7ca |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: KQ8 dateStart: 20010401 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: RPM dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1471-2415 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: M48 dateStart: 20010401 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: AAJSJ dateStart: 20011201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1471-2415 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020438 issn: 1471-2415 databaseCode: C6C dateStart: 20011201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR3bbtMw1NpFQrxM3AmMKkgIHiAsie3YeUBorTZNSJ1QRaUKHizXF0Cbkq7tGP17znGTQsaQeImU2I5sn6t9boS8yEqtnfZ5wrzmCTM5T0phTcJKbctUGu2C9Xx4WpyM2YcJn2yR1t222cDFjUc7rCc1np-__Xmxeg8E_y4QvCwOFsBjJbrSokUSUxtdvZxdJFhYCg2wTZWNbbILwipHxB-yjaEBI0NDtBzw6ASFWRtXc-NvO7IrpPj_m5H_Icmue1leM7UGCXZ8h-w1qmd8uMaVu2TLVffIrWFjXL9PvozqcxfXPkYX3_iHXtQ6MMMYU0oAJ8DBM3SCsdCriu18FbuVW8ShzHgMWjg8z1ww2zs_b8Yu1mHXD8j4-OjT4CRpai8kBs4Yy6SkmTWsKLgT3FHjnctlYUEfcJRbzrS23mMQ_XQqXTZNPTc5Hr6ocLRgmc3oQ7JT1ZV7TGILZJ9zqo3VDtgyndI8BRwwtPTaZYJG5HW7q2q2TrGhwtFEFmoNAwUwUAEG6ioifdz4TU9Mjx0-1POvqqE25aUsZSF0znTGvNG6dMLnZZpayY0wOiKvEGwK0QpgY3QTiwATxnRY6lAw0NQoE2lE9js9gfhMt7kFvGpxV-WYgScocxF5vmnGkejQVrn6EvukHG8EOCz_0RpPNkuiAvQ04KURkR0M6qy521J9_xZSg2doV0tL-OmbFtl-z-vfm_rkP-b5lNzOAy0w4Kz7ZGc5v3TPQCFbTntkW0xEj-z2j04_juBtUAx64XKjF4gNnqP-51_5pzfs |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2gQJBAHCBq4kecHBAqj6ql3R5QK63EwXj9AARKls2W1f4pfiMzTrJLiuDWyx7WdhR7Zr4ZZ16EPMlKrZ32NOFei4QbKpJSWpPwUtsyLYx2wXs-Osr3Tvj7sRhvkF99LgyGVfaYGIDa1ga_kW9TLGsSNOSr6Y8Eu0ahd7VvodGyxYFbLuDK1rzcfwv0fUrp7rvjN3tJ11UgMWA9z5OSZdbwPBdOCseMd44WuQVN55iwgmttvcf08MmkcNkk9cJQvFYw6VjOM5sxeO4FcpGzlGOtfjleX_DQq9Yn5hT5dgPYX2CIL3pKseTSYqD8Qo-AvzXBH6rwbJjmGV9tUIG718jVznaNd1pmu042XHWDXBp13vmb5OOH-ruLax9jjHD8Uze1DmgaY00KgBJcPMUoGguzqtjOlrFbuiYOfcpjMOPh95sLfn_nZ93aps3bvkVOzuWYb5PNqq7cXRJbwA0qmDZWO8B1NmE0BSYyrPTaZZJF5Hl_qmra1uhQ4W5T5KqlgQIaqEADtYjIazz41Uysrx3-qGefVSeuyhdFWeRSU64z7o3WpZOelmlqC2Gk0RF5hmRTiAJAG6O7ZAZ4YaynpXYkB1OPcZlGZGswE6TXDId7wqsOPRq15vWIPF4N40qMiKtcfYpzUoGfFARs_07LJ6stMQmGHoBxRIoBBw32PBypvn4JtcUzdMylJTz0Rc9s6_f696He-_82HpHLe8ejQ3W4f3Rwn1yhQSQ4IPQW2ZzPTt0DMOzmk4dBmmLy6bzF9zcEcGBb |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaglSouiDeBAkFC4gBRk9hO7OPyWJWFVgioVImD5dhjQKBktbul6r9nxskuTYEDlz3E41Xs8Tee0cx8YexJoa0FG8pMBCsz4UqZ6dq7TGjrda6chZg9Pzis9o_E7Fgen-vij9Xu65Rk39NALE3tam_uQw9xVe0t0aoqKp6lHCSRGZ1eZttK6grDr-3JZPZxtgm6KNO1bpb568zRhRR5-_-0zueup4ulkxfyp_Faml5jVwd_Mp30B-A6uwTtDbZzMGTMb7LPH7ofkHYhpbrd9KdddjZauJR4IhDeNHlOlS0epdrUL85SOINlGr8dnqJrjb_fIebiISyGucu-l_oWO5q-_vRyPxs-qJA5DBxWmeaFd6KqJNQSuAsApao8XvLApZfCWh8CdcY3jYKiyYN0JUVUvAZeicIX_DbbarsW7rLUI5ZLya3zFtDW8oaXOSrWcR0sFDVP2LP1rpp5z5thYryhKtPrwKAOTNSBOU3YC9r4jSRxXscH3eKLGSBkglJaVbUthS1EcNZqqEOp89wr6WpnE_aU1GYImagbZ4cGA3xh4rgyk1qg-8VFnSdsdySJiHLj4bXizYDopSmJVid6aAl7vBmmmVSl1kJ3QjK5pDBf4vLv9OdksyReo_OFBjJhanSCRmsej7Tfvka-74KSZbnGP32-Pmy_3-vfm3rv_8QfsZ33r6bm3ZvDt_fZlTIiRKAR3WVbq8UJPEDfa9U8HOD1CxS-Kcg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+tear+vasoactive+intestinal+peptide+on+dry+eyes+after+laser+keratorefractive+surgery&rft.jtitle=BMC+ophthalmology&rft.au=Kang%2C+Yang&rft.au=Hu%2C+Qi&rft.au=Li%2C+Xue&rft.au=Guo%2C+Zidan&rft.date=2023-04-20&rft.issn=1471-2415&rft.eissn=1471-2415&rft.volume=23&rft.issue=1&rft.spage=167&rft_id=info:doi/10.1186%2Fs12886-023-02857-w&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2415&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2415&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2415&client=summon |